Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Tumors and the danger model.

Dariusz W Kowalczyk¹

¹Department of Cancer Immunology, K Marcinkowski University School of Medical Sciences, GreatPoland Cancer Center, Poznań. dkowalczyk@wco.pl

Acta Biochimica Polonica

|October 5, 2002

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Evaluation of the liver load index as a predictor of liver exposure in right breast radiotherapy.

Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology·2025

Same author

Clinical and In Vitro Studies on Impact of High-Dose Etoposide Pharmacokinetics Prior Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Lymphoblastic Leukemia on the Risk of Post-Transplant Leukemia Relapse.

Archivum immunologiae et therapiae experimentalis·2015

Same author

Drug efflux transporter multidrug resistance-associated protein 5 affects sensitivity of pancreatic cancer cell lines to the nucleoside anticancer drug 5-fluorouracil.

Drug metabolism and disposition: the biological fate of chemicals·2010

Same author

Captopril, an angiotensin-converting enzyme inhibitor, promotes growth of immunogenic tumors in mice.

Clinical cancer research : an official journal of the American Association for Cancer Research·2006

Same author

Expression of soluble recombinant TGF-beta type II receptor fused with the Fc portion of human IgG1 (sTbetaRII-Fc) in NS0 cells.

Acta biochimica Polonica·2006

Same author

Vaccine-induced CD8+ T cells eliminate tumors by a two-staged attack.

Cancer gene therapy·2004

The immune system fails to detect tumors because cancer cells lack danger signals. Dendritic cells must be activated to initiate an anti-tumor immune response, preventing immune evasion.

Area of Science:

Immunology
Oncology
Cancer Research

Background:

Tumors possess potential immunogenicity but often evade immune destruction.
The immune system's failure to eliminate malignant cells necessitates understanding immune surveillance mechanisms.

Purpose of the Study:

To review evidence supporting the danger model in tumor immunology.
To elucidate the role of dendritic cell activation in initiating anti-tumor immune responses.

Main Methods:

Review of studies involving model tumor antigens.
Analysis of data from recombinant viral vectors.
Evaluation of tumor-specific T-cell detection using MHC/peptide tetramers.

Main Results:

Related Experiment Videos

Tumor cells fail to elicit significant immune responses due to a lack of danger signals.

Activated dendritic cells, not resting or cancer cells, are crucial for presenting tumor antigens.

Tumor escape is facilitated by the inability of dendritic cells to become activated, inducing tolerance.

Conclusions:

The danger model explains immune surveillance failure in cancer.
Dendritic cell activation is critical for effective anti-tumor immunity.
Targeting dendritic cell activation may overcome tumor immune evasion.